Published April 2019 | Version v1
Journal article

New mechanistic insights into osmium-based tamoxifen derivatives

  • 1. Chimie ParisTech, PSL University, 11 Rue Pierre et Marie Curie, 75005, Paris (France)
  • 2. Université Paris Diderot, Sorbonne Paris Cité, ITODYS CNRS UMR 7086, 15 Rue Jean-Antoine de Baïf, 75205, Paris Cedex 13 (France)
  • 3. PASTEUR, Département de chimie, École Normale Supérieure, PSL University, Sorbonne Université, CNRS, 75005, Paris (France)
  • 4. Sorbonne Université, CNRS, IPCM, 4 Place Jussieu, 75005, Paris (France)

Description

Highlights: • Electrochemical behavior of an organometallic osmium-based anticancer drug candidate. • Mechanistic investigations by cyclic voltammetry. • Evidence of a stable quinone methide carbocation intermediate. -- Abstract: The electrochemical behavior of osmociphenol (3, Oc-OH), an organometallic osmium-based anticancer drug candidate, has been investigated by cyclic voltammetry in the absence and presence of lutidine used as a base model. Osmociphenol exhibited spontaneous deprotonation of the phenol function upon oxidation of the osmocene moiety due to its high acidity. In the presence of lutidine, a base-dependent and different electrochemical behavior was observed at low scan rates indicating a second oxidation step leading to the corresponding cationic quinone methide precursor (3b+). However, compared to ruthenocene derivatives, the stability of 3b+ prevented its conversion into quinone methide as the final and stable complex. Despite differences in their oxidative processes, osmociphenol and ruthenociphenol derivatives exhibit similar biological activities.

Additional details

Additional titles

Augmented title (English)
Bioorganometallic;Cyclic voltammetry;Osmium;Anti-cancer;Tamoxifen

Identifiers

DOI
10.1016/j.electacta.2019.02.019;
PII
S0013468619302440;

Publishing Information

Journal Title
Electrochimica Acta
Journal Volume
302
Journal Page Range
p. 130-136
ISSN
0013-4686
CODEN
ELCAAV

Optional Information

Copyright
Copyright (c) 2019 Elsevier Ltd. All rights reserved.